Literature DB >> 11406572

A white paper: the product of a pancreas cancer think tank.

S Kern1, R Hruban, M A Hollingsworth, R Brand, T E Adrian, E Jaffee, M A Tempero.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11406572

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  34 in total

Review 1.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

2.  Changes in connexin43 expression and localization during pancreatic cancer progression.

Authors:  Joell L Solan; Sunil R Hingorani; Paul D Lampe
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

3.  Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.

Authors:  Sally E Dowen; Tatjana Crnogorac-Jurcevic; Rathi Gangeswaran; Mikkel Hansen; Jyrki J Eloranta; Vipul Bhakta; Teresa A Brentnall; Jutta Lüttges; Gunther Klöppel; Nick R Lemoine
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

4.  Development of a VX2 pancreatic cancer model in rabbits: a pilot study.

Authors:  Aaron C Eifler; Robert J Lewandowski; Sumeet Virmani; Johnathan C Chung; Dingxin Wang; Richard L Tang; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Robert K Ryu; Riad Salem; Andrew C Larson; Eric Cheon; Matthew Strouch; David J Bentrem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2009-06-28       Impact factor: 3.464

5.  Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma.

Authors:  Douglas D Benson; Xianzhong Meng; David A Fullerton; Ernest E Moore; Joon H Lee; Lihua Ao; Christopher C Silliman; Carlton C Barnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

Review 6.  Role of protein kinase D signaling in pancreatic cancer.

Authors:  Sushovan Guha; Suebpong Tanasanvimon; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Pharmacol       Date:  2010-07-16       Impact factor: 5.858

7.  High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.

Authors:  Ross Smith; AiQun Xue; Anthony Gill; Christopher Scarlett; Alexander Saxby; Adele Clarkson; Thomas Hugh
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Effect of p120 catenin silencing on biological behaviors of PANC-1 cells.

Authors:  Zhangjun Cheng; Volker Assfag; Xin Shi; Shibo Lin; Jiangyan Xia; Pinghua Yang; Norbert Hüser; Feng Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

10.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Authors:  Elena Ortiz-Zapater; Sandra Peiró; Oriol Roda; Josep M Corominas; Susana Aguilar; Coral Ampurdanés; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.